PURPOSE OF THE STUDY:
Major fish allergens can withstand extensive cooking. Most children with bony fish allergy strictly avoid fish, but some may tolerate canned fish. This study reviewed the safety of children with fish allergy consuming canned fish.
STUDY POPULATION:
Children (n = 53; ages 1–18 years) with clinically confirmed fish allergy and 4 controls were recruited at the Children’s Hospital at Westmead, Australia.
METHODS:
The content and integrity of parvalbumin in 17 canned fish products (salmon n = 8; tuna n = 7; sardine n = 2) were examined by allergen-specific antibodies (sIgE). The sIgE binding of 5 products was evaluated in children with fish allergy, and sIgE-binding proteins were identified by mass spectrometry.
RESULTS:
Compared with cooked fish, canned fish showed reduced parvalbumin content and sIgE binding. Heat-stable parvalbumin, tropomyosin, and collagen allergens maintained their sIgE-binding capacity. Of the 53 children, 13 passed oral challenges to cooked salmon or tuna; 66% had sIgE binding to canned fish proteins: 51% to sardine, 43% to 45% to salmon, and 8% to 17% to tuna. Parvalbumin demonstrated greatest sIgE binding in sardine and salmon. Tropomyosin was relevant for tuna sIgE binding.
CONCLUSIONS:
Canned fish products are not safe for all children with bony fish allergy. Their introduction should be carefully considered using sIgE to heat-stable fish allergens and monitored oral food challenges as appropriate.
REVIEWER COMMENTS:
This study highlights the variability of bony fish proteins present in canned fish, the distinction between sIgE content and binding capacity, and evaluation of new proteins that may, in the future, become registered allergens. The findings also underscore the importance of careful clinical evaluation by allergy testing and monitored oral challenge as indicated, before recommending introduction of canned fish into the diet of children with bony fish allergy.
Comments